Newsroom

I discovered the world of microbiology & immunology. I was fascinated with disease causing bacteria and viruses, and their impact on society.

In the era of Manufacturing 4.0, the life sciences industry faces unprecedented challenges in validating computerised systems.

The most fulfilling reward in Med-Tech product development is witnessing the final product actively transforming the lives of patients.

ALTEN today announces that it has signed a Share & Asset Purchase Agreement with Atos SE (“Atos”) for the purchase of Atos’ Worldgrid business unit.

Writings with molecules and standards as main characters

Our Group’s ability to develop and promote the best talents available is fundamental in enabling us to meet our customers’ needs.

Find out more about our third quarter 2024 financial results.

For the third year running, the Group joins the 19 French companies rewarded for the excellence of their management and their ability to innovate and meet the challenges of tomorrow.

The Japan Aerospace Exploration Agency (JAXA) is preparing a Martian Moons eXploration (MMX), scheduled to be launched in 2027.

ALTEN has been working alongside the French Astrophysics and Planetology Research Institute to expand the boundaries of our knowledge of the cosmos and open new avenues for space exploration.

Rui Campos is emblematic of what ALTEN has to offer in terms of career development. Initially an automation expert and now a life sciences leader.

Clinical trials are essential research studies evaluating medical intervention safety and efficacy.